Medicus Pharma (MDCX) Other Working Capital Changes (2024 - 2025)

Medicus Pharma (MDCX) posted Other Working Capital Changes of -$36441.0 for Q4 2025, up 83.39% quarter-over-quarter from -$219372.0 in Q3 2025, and down 4.0% year-on-year from -$37958.7 in Q4 2024.

Medicus Pharma (MDCX) Other Working Capital Changes (2024 - 2025) Analysis & Trends

Medicus Pharma (MDCX) has reported Other Working Capital Changes for 2 consecutive years, with -$36441.0 the latest figure, recorded in Q4 2025.

  • Other Working Capital Changes for Q4 2025 came in at -$36441.0, down 4.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$142612.0 (down 103.5% YoY), and the FY2025 annual result was -$142612.0, down 103.5% from the prior year.
  • Other Working Capital Changes was -$36441.0 for Q4 2025 at Medicus Pharma, up from -$219372.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $140776.0 in Q2 2025 and troughed at -$219372.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Medicus Pharma 6.91 Mn -1.69 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -36,441.00
Dec 31, 2025 -36,441.00
Dec 31, 2025 -36,441.00
Sep 30, 2025 -219,372.00
Sep 30, 2025 -219,372.00
Sep 30, 2025 -219,372.00
Jun 30, 2025 140,776.00
Jun 30, 2025 140,776.00
Jun 30, 2025 140,776.00
Mar 31, 2025 -27,575.00
Mar 31, 2025 -27,575.00
Mar 31, 2025 -27,575.00
Dec 31, 2024 -35,040.00
Dec 31, 2024 -35,040.00
Dec 31, 2024 -35,040.00
Sep 30, 2024 5,523.00
Sep 30, 2024 5,523.00
Sep 30, 2024 5,523.00
Jun 30, 2024 -40,563.00
Jun 30, 2024 -40,563.00